Dr Robyn Laube – Sydney Gastroenterologist

Gastroenterology training

Dr Laube is an accredited Gastroenterologist and Hepatologist. She graduated medical school with distinction from the University of NSW. She completed her advanced Gastroenterology training at Concord Repatriation General Hospital and a fellowship at Macquarie University Hospital. She completed a PhD in IBD in Pregnancy at Macquarie University.

Expertise

Dr Laube treats all aspects of gastrointestinal and liver disorders, and is passionate about providing high quality individualised care to each of her patients. Her subspecialty interest is inflammatory bowel disease (IBD) and women’s health including pregnancy. Other clinical interests include:

• Colon polyp surveillance
• Positive faecal occult blood test (FOBT) / National Bowel Cancer Screening Program
• Rectal bleeding and haemorrhoids
• Iron deficiency
• Constipation and diarrhoea
• Reflux
• Irritable bowel syndrome (IBS)
• Dysphagia
• Fatty liver disease
• Liver diseases and hepatitis

Dr Laube is experienced and qualified in gastrointestinal procedures, including:

• Gastroscopy
• Colonoscopy
• Sigmoidoscopy
• Capsule endoscopy
• Polypectomy
• Haemorrhoid banding 
• Chromoendoscopy

Locations

• Private consulting at Sydney Gastrointestinal Specialists (38 Denistone Road, Eastwood)
• Private consulting at Forum Specialists Leichhardt (Italian Forum, Leichhardt)
• Public inpatient consulting and public endoscopy (gastroscopy and colonoscopy) at Ryde Hospital
• Private inpatient consulting and private endoscopy (gastroscopy and colonoscopy) at Macquarie University Hospital
• Private endoscopy (gastroscopy and colonoscopy) at Sydney Day Surgery, Newtown

Research and academia

Dr Laube has a strong academic career with multiple publications in peer reviewed Gastroenterology journals. She published the first national Australian guidelines for the management of pre-conception, pregnancy and breastfeeding in patients with Inflammatory Bowel Disease. She completed a PhD on pregnancy in IBD, and has been awarded the prestigious RACP Basser Research Entry Scholarship. She is actively involved in teaching and holds a Conjoint Lecturer position at Macquarie University.

Key publications

Laube, R., Selinger, C. Seow. C., Christensen, B., Flanagan, E., Kennedy, D., Mountifield, R., Seeho, S., Shand, A., Williams, A., Leong, R. Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding. Gut. 2023; doi:10.1136/gutjnl-2022-329304  

Selinger, C., Laube, R., Fraser, A., Headley, K., Kent, A., Kok, K., Newman, V., Limdi, J., Ludlow, H., Rees,
F., Sagar, N., Walker, N. Appropriateness of small molecule agents for patients with IBD of childbearing
age – a RAND/UCLA appropriateness panel. Therapeutic Advances in Gastroenterology. Forthcoming
2024

Arzivian, A., Zhang, E., Laube, R., Leong, R. First-trimester exposure to tofacitinib in ulcerative colitis:
A case report of a healthy newborn and literature review. Clinical Case Reports. 2024; 12 (4), e8764

Monfared, N., Gold, M., Carbery, I., Laube, R., Selinger, C. Systematic review: reproductive safety
issues of novel small molecules for the treatment of Inflammatory Bowel Disease. Journal of Clinical
Medicine. 2024; 13 (34): 1-10

Laube, R. and Liu, K. (2023). Gut microbiome and immune responses in gastrointestinal cancer. In J. (Ed), Microbiome and Gastrointestinal Cancer, (chapter 11). Springer Nature, Singapore.

Laube, R., Selinger, C., Leong, R. Medication adherence in women with IBD of childbearing age likely associated with disease knowledge. Therapeutic Advances in Gastroenterology (2022): 15, 1-8

Laube, R., Liu, E., Li, Y., Leong, R., Selinger, C., Limdi, J. Gastroenterology team members knowledge and practices with fertility therapy for women living with inflammatory bowel disease. Therapeutic Advances in Gastroenterology. 2022; 15:17562848221087543

Liu, E., Laube, R., Leong, R., Fraser, A., Limdi, J., Selinger, C. Managing IBD in pregnancy: healthcare professionals involvement, knowledge and decision making – a cross-sectional study. Inflammatory Bowel Diseases. 2022; izac101. doi:10.1093/ibd/izac101

Laube, R., Tran, Y., Paramsothy, S., Leong, R. Assisted reproductive technology in inflammatory bowel disease: a systematic review and meta-analysis. American Journal of Gastroenterology. 2021; 116: 2334-2344

Laube, R., Paramsothy, S., Leong, R. Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis. Expert Opinion on Drug Safety. 2021; 20(3): 275-292

Laube, R., Paramsothy, S., Leong, R. Review of pregnancy in Crohn’s disease and ulcerative colitis. Therapeutic Advances in Gastroenterology. 2021; 14:1-18

Laube, R., Rickard, M., Lee, A. Small intestinal blue rubber bleb nevus syndrome. Journal of Gastroenterology and Hepatology. 2021; 36: 2637

Laube, R., Selinger, C. Editorial: standardising inclusion and outcome criteria for pouchitis – a fragile consensus perhaps but a first step in the right direction. Alimentary Pharmacology & Therapeutics. 2021; 53: 1147-48

Laube, R., Yau, Y., Selinger, C., Thomas, A., Ahuja, V., Alharbi, O., Banerjee, R., Chuah, S., Hilmi, I., Mao, R., Ng, SC., Ong, D., Seow, CH., Wei, SC., Leong, RW. Knowledge and attitudes towards pregnancy in females with inflammatory bowel disease – an international multi-centre study. Journal of Crohn’s and Colitis. 2020; 14(9): 1248-1255

Laube, R., Sabih, A., Strasser, S., Lim, L., Cigolini, M., Liu, K. Palliative care in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 2020; 36: 618-628

Sabih, A., Laube, R., Strasser, S., Lim, L., Cigolini, M., Liu, K. Clinician experience and attitudes towards palliative care referrals in patients with hepatocellular carcinoma. BMJ Supportive & Palliative Care. 2021; pending publication

Shir Ali, M., Laube, R., Selvaratnam, S., Leong, R. Tioguanine as an alternative immunomodulator in inflammatory bowel diseases. Internal Medicine Journal. 2020; 50(11): 1434-35

Laube, R. and Selinger, C. (2020). Re: Roberti R, Iannone LF, Palleria C, et al. Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy. Current Medical Research and Opinion. 2020; 36(10):1627-28

Laube, R. and Selinger, C. (2020). Letter: Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications. Alimentary Pharmacology & Therapeutics. 2020; 51: 915-917

Laube, R., Leong, RW., Hui, J., Shir Ali, M., Kariyawasam, V. Audit of CMV colitis detected by immunohistochemistry and polymerase chain reaction in IBD patients. Journal of Gastroenterology and Hepatology. 2019; 34: 120

Laube, R. and Liu, K. An unwanted complement: rare case of potential liver injury induced by an interaction between ginseng and atorvastatin. British Journal of Clinical Pharmacology. 2019; 85(7): 1612-1613 

Laube, R., Wang, H., Park, L., Heyman, J., Vidot, H., Majumdar, A., Strasser, S., McCaughan, G., Liu, K. Frailty in advanced liver disease. Liver International. 2018; 38(12): 2117-2128.

Laube, R., Liu, K., Schifter, M., Yang, J., Suen, M., Leong, R. Review article: oral and upper gastrointestinal Crohn’s disease. Journal of Gastroenterology and Hepatology. 2018; 33(2): 355-364.

Mok, J., Ong, D., Hartono, J., Gowans, M., Weihao, C., Yip, C., Laube, R., Leong, R. Negative attitudes and beliefs of women with IBD pose risk for voluntary childlessness. 2018.

Laube, R., Shir Ali, M., Leong, R. Access to out-of-hours rescue therapy for acute severe ulcerative colitis in Australia. Journal of Gastroenterology and Hepatology. 2018; 33 (supp2): 98-99

Laube, R., Liu, K., Katelaris, P. Dysphagia aortica. Journal of Gastroenterology and Hepatology. 2015; 30(5): 799.